CorMedix Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CorMedix Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • CorMedix Inc. Return On Equity for the quarter ending September 30, 2024 was -79.2 %, a 20% decline year-over-year.
  • CorMedix Inc. annual Return On Equity for 2023 was -72.3 %, a 41.8% decline from 2022.
  • CorMedix Inc. annual Return On Equity for 2022 was -51 %, a 30.7% decline from 2021.
  • CorMedix Inc. annual Return On Equity for 2021 was -39 %, a 47.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -79.2 -13.2 -20% Jul 1, 2024 Sep 30, 2024
Q2 2024 -82.5 -13.6 -19.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -77.2 -18.6 -31.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -72.3 -21.3 -41.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -66 -17.3 -35.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -68.9 -20 -40.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -58.6 -16.9 -40.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -51 -12 -30.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48.7 -9.5 -24.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.9 -7.26 -17.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -41.7 +11.7 +21.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -39 +35.2 +47.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -39.2 +47.4 +54.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -41.6 +44.5 +51.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -53.4 +21.1 +28.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -74.2 +2.83 +3.68% Oct 1, 2020 Dec 31, 2020
Q3 2020 -86.5 -32.6 -60.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -86.1 +110 +56.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -74.4 +1.51K +95.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -77 -1.13K -107% Oct 1, 2019 Dec 31, 2019
Q3 2019 -53.9 -2.03K -103% Jul 1, 2019 Sep 30, 2019
Q2 2019 -196 +1.19K +85.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.59K -1.16K -268% Jan 1, 2019 Mar 31, 2019
Q4 2018 1.05K +1.36K Oct 1, 2018 Dec 31, 2018
Q3 2018 1.98K +2.19K Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.39K -1.22K -735% Apr 1, 2018 Jun 30, 2018
Q1 2018 -431 -292 -210% Jan 1, 2018 Mar 31, 2018
Q4 2017 -305 -207 -212% Oct 1, 2017 Dec 31, 2017
Q3 2017 -216 -154 -246% Jul 1, 2017 Sep 30, 2017
Q2 2017 -166 -138 -495% Apr 1, 2017 Jun 30, 2017
Q1 2017 -139 -127 -1057% Jan 1, 2017 Mar 31, 2017
Q4 2016 -97.9 -78.8 Oct 1, 2016 Dec 31, 2016
Q3 2016 -62.3 -25.8 Jul 1, 2016 Sep 30, 2016
Q2 2016 -28 +67.1 Apr 1, 2016 Jun 30, 2016
Q1 2016 -12 +231 +95.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -19.2* +2.09K Oct 1, 2015 Dec 31, 2015
Q3 2015 -36.6* -2.33K Jul 1, 2015 Sep 30, 2015
Q2 2015 -95.1* -728 Apr 1, 2015 Jun 30, 2015
Q1 2015 -243 -1.03K -131% Jan 1, 2015 Mar 31, 2015
Q4 2014 -2.11K -2.48K -672% Oct 1, 2014 Dec 31, 2014
Q3 2014 2.3K +1.88K +447% Jul 1, 2014 Sep 30, 2014
Q2 2014 633 +118 +23% Apr 1, 2014 Jun 30, 2014
Q1 2014 786 +57 +7.82% Jan 1, 2014 Mar 31, 2014
Q4 2013 368 -2.35K -86.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 420 +1.16K Jul 1, 2013 Sep 30, 2013
Q2 2013 515 +1.15K Apr 1, 2013 Jun 30, 2013
Q1 2013 729 +1.12K Jan 1, 2013 Mar 31, 2013
Q4 2012 2.72K Oct 1, 2012 Dec 31, 2012
Q3 2012 -735 Jul 1, 2012 Sep 30, 2012
Q2 2012 -635 Apr 1, 2012 Jun 30, 2012
Q1 2012 -391 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.